Rare diseases
Investigational molecules
Locations
Harburger Ring 10, 21073 Hamburg, Germany
The medical center is at the forefront of oncology research, with a particular focus on breast cancer. The institution is dedicated to advancing treatment options for patients with ER+/HER2- early breast cancer, a subtype that requires specialized therapeutic approaches.
Through its research, the center aims to demonstrate the superiority of extended therapy with innovative agents like camizestrant over traditional endocrine therapies, thereby contributing to the reduction of cancer recurrence rates and improving patient outcomes.
Clinical trials currently enrolling participants at this site.
GermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
